dndn: update from inside the j.p morgan conf, page-7

"Who said DNDN is going to fall 80 %?Unless you've a crytsal ball?I love your scare tactics."

What is wrong with you? I didn't even suggest that I thought DNDN was going to fall 80% from this level - I was alluding to the fact that DNDN may be uncoupled from PRR in that IF DNDN were to fall 80%, or even 99%, or even 99.99%, what would happen to PRR? If DNDN were to rise by 200% and regain the SP before the decline, would PRR follow?

Just calm down.

"I am however intrigued by your question if DNDN were to fall 80% from this level. A drop of 80% from the current $13.31 would be a sp of about $2.67 an outrageously low figure , so why even contemplate it, particularly as it seems that there could be further marked improvement for Dendreon as it is moving to expand Provenge to Europe. "

A very valid argument. My number of '80' was plucked out of the air to illustrate my point about the possible decoupling.

"If dendreon goes up and PRR goes down its not due to Dendreon having gone up lol. "

Finally, a shred of thoughtful discussion on the PRR forum. It's like trying to find specks of gold in a pile of dirt. Now in my opinion, PRR and DNDN needs to have some form of positive correlation for investors to be confident. Yes, the products/technology is different, but both companies are in a pioneering sector that could take the world by storm in a couple of decades (not saying PRR/DNDN will do this, but they are making inroads).

Now, your logic is right in saying that if DNDN goes up and PRR goes down, PRR's drop is not because of DNDN going up - but your axiom is a double edged sword in that PRR has dropped, for whatever reason, a reason that has more effect on the share price than DNDN's massive recovery over the past few days. Apart from company news, what could be more bullish than a company in the same pioneering sector finally getting together its marketing/business model? If anything it's hugely positive in that it reinforces that PRR (bleeding edge technology) is actually commercially viable. And yet the share price has fallen, and it's fallen because there's another reason which is overshadowing DNDN's recent good news. That's very bearish in my opinion.

For the sake of your money, I hope this is a one-off case of decoupling or something's very, very wrong.

"Im sick of hearing about DNDN, I'm pretty sure I bought shares in PRR. Fools."

You've invested your hard-earned in PRR and you call those who discuss a company that has walked the SAME path PRR is about to in the SAME bleeding edge healthcare sector dealing with the SAME authorities that will sanction its commercialisation, fools. Have you remembered to take your meds?